2590-0536

Biosafety and Health

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 366 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact366 DOIs
2

Attach ORCID iDs across 238 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact238 DOIs
3

Deposit reference lists for 11 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact11 DOIs

DOIs for this ISSN

Showing the top 5 of 366 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Use of antimicrobials in food animals and impact of transmis… (10.1016/j.bsheal.2020.09.004)
Abstract ORCID
125.53 323
2 Assessment of the SARS-CoV-2 basic reproduction number, R0,… (10.1016/j.bsheal.2020.03.004)
Abstract ORCID
116.62 214
3 Cold-chain transportation in the frozen food industry may ha… (10.1016/j.bsheal.2020.11.003)
Abstract ORCID
112.52 177
4 A review of artificial intelligence applications for antimic… (10.1016/j.bsheal.2020.08.003)
Abstract ORCID
107.92 143
5 A strategy to prevent future epidemics similar to the 2019-n… (10.1016/j.bsheal.2020.01.003)
Abstract ORCID
103.78 118
6 Charting the challenges behind the testing of COVID-19 in de… (10.1016/j.bsheal.2020.05.002)
Abstract ORCID
101.27 105
7 An update to monoclonal antibody as therapeutic option again… (10.1016/j.bsheal.2021.02.001)
Abstract ORCID
100.85 103
8 Technical guidance for laboratory testing of 2019-nCoV infec… (10.1016/j.bsheal.2020.02.001)
Abstract References ORCID
99.17 20
9 Prevalence and transmission of mobilized colistin resistance… (10.1016/j.bsheal.2020.05.001)
Abstract ORCID
97.95 90
10 Development and effectiveness of pseudotyped SARS-CoV-2 syst… (10.1016/j.bsheal.2020.08.004)
Abstract ORCID
93.17 72
11 Surveillance, epidemiology, and pathogen spectrum of hand, f… (10.1016/j.bsheal.2019.02.005)
Abstract ORCID
92.87 71
12 The prevalence and distribution of aminoglycoside resistance… (10.1016/j.bsheal.2023.01.001)
Abstract ORCID
89.62 61
13 Advanced biosafety materials for prevention and theranostics… (10.1016/j.bsheal.2022.03.011)
Abstract ORCID
82.66 44
14 Development of two multiplex real-time PCR assays for simult… (10.1016/j.bsheal.2022.10.005)
Abstract ORCID
82.66 44
15 SARS-CoV-2: A critical review of its history, pathogenesis,… (10.1016/j.bsheal.2020.11.002)
Abstract ORCID
82.17 43
16 Omicron variant of SARS-CoV-2 imposes a new challenge for th… (10.1016/j.bsheal.2022.01.002)
Abstract ORCID
81.16 41
17 Facing the 2020 pandemic: What does cyberbiosecurity want us… (10.1016/j.bsheal.2020.09.007)
Abstract ORCID
80.10 39
18 Biosafety chemistry and biosafety materials: A new perspecti… (10.1016/j.bsheal.2022.01.001)
Abstract ORCID
78.41 36
19 Yersinia pestis, a problem of the past and a re-emerging thr… (10.1016/j.bsheal.2019.09.001)
Abstract ORCID
75.93 32
20 Molecular evolution and genetic diversity analysis of SFTS v… (10.1016/j.bsheal.2021.02.002)
Abstract ORCID
75.93 32
21 Biosafety assessment of delivery systems for clinical nuclei… (10.1016/j.bsheal.2022.03.003)
Abstract ORCID
73.12 28
22 Clinical characteristics of patients diagnosed with COVID-19… (10.1016/j.bsheal.2020.05.003)
Abstract ORCID
72.36 27
23 SARS-CoV-2 spike protein and RNA dependent RNA polymerase as… (10.1016/j.bsheal.2021.07.003)
Abstract ORCID
71.57 26
24 Ti-MOF-based biosafety materials for efficient and long-life… (10.1016/j.bsheal.2022.02.001)
Abstract ORCID
71.57 26
25 Molecular targets for COVID-19 drug development: Enlightenin… (10.1016/j.bsheal.2020.07.002)
Abstract ORCID
70.75 25
26 Genomic characterization of SARS-CoV-2 identified in a reeme… (10.1016/j.bsheal.2020.08.006)
Abstract ORCID
70.75 25
27 Spatiotemporal patterns and trends of community transmission… (10.1016/j.bsheal.2020.09.006)
Abstract ORCID
70.75 25
28 The multi-kingdom microbiome catalog of the chicken gastroin… (10.1016/j.bsheal.2024.02.006)
Abstract ORCID
70.75 25
29 Advances and challenges of mpox detection technology (10.1016/j.bsheal.2024.09.005)
Abstract ORCID
70.75 25
30 Expression pattern and function of SARS-CoV-2 receptor ACE2 (10.1016/j.bsheal.2021.08.003)
Abstract ORCID
69.90 24
31 Automated robot and artificial intelligence-powered wastewat… (10.1016/j.bsheal.2024.07.002)
Abstract ORCID
69.01 23
32 For a better world: Biosafety strategies to protect global h… (10.1016/j.bsheal.2019.03.001)
Abstract ORCID
68.09 22
33 Estimation of the case fatality rate of COVID-19 epidemiolog… (10.1016/j.bsheal.2020.09.003)
Abstract ORCID
68.09 22
34 Antimicrobial peptide-inspired antibacterial polymeric mater… (10.1016/j.bsheal.2022.03.009)
Abstract ORCID
68.09 22
35 Influencing factors on the preservation of lytic bacteriopha… (10.1016/j.bsheal.2022.06.004)
Abstract ORCID
68.09 22
36 Immunologically effective biomaterials-enhanced vaccines aga… (10.1016/j.bsheal.2022.11.002)
Abstract ORCID
68.09 22
37 Laboratory biosafety guide for 2019-nCoV (Second Edition) (10.1016/j.bsheal.2020.01.001)
Abstract References ORCID
67.73 7
38 Risks and challenges of HIV infection transmitted via blood… (10.1016/j.bsheal.2019.12.001)
Abstract ORCID
67.12 21
39 Towards precision medicine: Omics approach for COVID-19 (10.1016/j.bsheal.2023.01.002)
Abstract ORCID
67.12 21
40 Single virus tracking of Ebola virus entry through lipid raf… (10.1016/j.bsheal.2019.12.009)
Abstract ORCID
66.11 20
41 The correlation of drug resistance and virulence in Mycobact… (10.1016/j.bsheal.2020.02.004)
Abstract ORCID
66.11 20
42 Biohazard levels and biosafety protection for Mycobacterium… (10.1016/j.bsheal.2020.04.001)
Abstract ORCID
66.11 20
43 Evaluating human exposure to antibiotic resistance genes (10.1016/j.bsheal.2024.02.005)
Abstract ORCID
66.11 20
44 Biosafety considerations triggered by genome-editing technol… (10.1016/j.bsheal.2025.05.003)
Abstract ORCID
66.11 20
45 Therapeutic implications of prion diseases (10.1016/j.bsheal.2020.09.001)
Abstract ORCID
65.05 19
46 Laboratory biosafety in China: past, present, and future (10.1016/j.bsheal.2019.10.003)
Abstract ORCID
63.94 18
47 Herpes B virus: History, zoonotic potential, and public heal… (10.1016/j.bsheal.2022.05.005)
Abstract ORCID
63.94 18
48 Point-of-need molecular processing of biosamples using porta… (10.1016/j.bsheal.2020.06.001)
Abstract ORCID
62.76 17
49 Laboratory-acquired infections with Brucella bacteria in Chi… (10.1016/j.bsheal.2020.07.010)
Abstract ORCID
62.76 17
50 Convincing the confidence to conquer COVID-19: From epidemio… (10.1016/j.bsheal.2020.11.005)
Abstract ORCID
62.76 17